Sutton Wealth Advisors Inc. Vertex Pharmaceuticals Inc Transaction History

Sutton Wealth Advisors Inc.

  • $203 Billion
  • Q3 2023

A detailed history of Sutton Wealth Advisors Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sutton Wealth Advisors Inc. holds 94 shares of VRTX stock, worth $38,423. This represents 0.02% of its overall portfolio holdings.

Number of Shares
94
Previous 79 18.99%
Holding current value
$38,423
Previous $27.8 Million 17.58%
% of portfolio
0.02%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$338.18 - $362.46 $5,072 - $5,436
15 Added 18.99%
94 $32.7 Million
Q1 2023

Nov 07, 2023
SELL
$283.23 - $323.1 $1,982 - $2,261
-7 Reduced 8.14%
79 $24.9 Million
Q3 2022

Nov 07, 2023
SELL
$273.83 - $305.53 $273 - $305
-1 Reduced 1.15%
86 $24.9 Million
Q1 2022

Nov 07, 2023
BUY
$221.42 - $260.97 $1,549 - $1,826
7 Added 8.75%
87 $22.7 Million
Q4 2021

Nov 07, 2023
BUY
$177.01 - $223.45 $5,133 - $6,480
29 Added 56.86%
80 $17.6 Million
Q3 2021

Nov 07, 2023
SELL
$181.39 - $202.99 $2,176 - $2,435
-12 Reduced 19.05%
51 $9.25 Million
Q2 2021

Nov 07, 2023
BUY
$187.49 - $221.1 $937 - $1,105
5 Added 8.62%
63 $12.7 Million
Q1 2021

Nov 07, 2023
SELL
$207.02 - $241.31 $2,070 - $2,413
-10 Reduced 14.71%
58 $12.5 Million
Q4 2020

Nov 07, 2023
BUY
$207.01 - $276.09 $1,449 - $1,932
7 Added 11.48%
68 $16.1 Million
Q2 2020

Nov 07, 2023
BUY
$225.48 - $295.8 $676 - $887
3 Added 5.17%
61 $17.7 Million
Q1 2020

Nov 07, 2023
BUY
$199.77 - $247.81 $1,797 - $2,230
9 Added 18.37%
58 $13.8 Million
Q2 2019

Nov 06, 2023
BUY
$164.61 - $190.37 $329 - $380
2 Added 4.26%
49 $8.99 Million
Q1 2019

Nov 06, 2023
BUY
$163.73 - $194.7 $818 - $973
5 Added 11.9%
47 $8.65 Million
Q2 2018

Nov 06, 2023
SELL
$145.72 - $169.96 $16,466 - $19,205
-113 Reduced 72.9%
42 $7.14 Million
Q4 2017

Nov 06, 2023
BUY
$137.28 - $155.55 $16,061 - $18,199
117 Added 307.89%
155 $23.2 Million
Q2 2017

Nov 06, 2023
BUY
N/A
13 Added 52.0%
38 $4.9 Million
Q1 2017

Nov 06, 2023
SELL
N/A
-6 Reduced 19.35%
25 $2.73 Million
Q4 2016

Nov 06, 2023
SELL
N/A
-294 Reduced 90.46%
31 $2.28 Million
Q3 2016

Nov 06, 2023
BUY
N/A
15 Added 4.84%
325 $28.3 Million
Q1 2016

Nov 06, 2023
BUY
N/A
310
310 $24.6 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email